• Aucun résultat trouvé

[PDF] Top 20 Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

Has 10000 "Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study." found on our website. Below are the top 20 most common "Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.".

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

... Schmitt and Jutta Kneisel for their assistance during the collection of hormone receptor status data, and we thank all the EPIC cohort participants for their contributions to ... Voir le document complet

15

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

... European Prospective Investigation into Cancer and Nutrition (EPIC) is a multi-center prospective cohort study designed to investigate the relationships between diet, ... Voir le document complet

13

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

... known risk factors for breast cancer: age at menarche (<13, 13–14, or ≥15 years); height (continuous); body mass index category (time-dependent variable according to height at baseline ... Voir le document complet

18

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.

... Material and Methods E3N is a French prospective study investigating cancer risk factors in 98,997 women born between 1925 and ...MGEN, a health insurance scheme ... Voir le document complet

13

Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study.

Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study.

... Strengths and limitations of the study Limitations to this study include the 6-year follow-up and small number of deaths which was insufficient to examine in detail specific causes of ... Voir le document complet

8

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

... postmenopausal breast cancer risk associated with past OC use and the decrease in risk with increasing time since first use support the hypothesis that some women develop ... Voir le document complet

11

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

... the use of natural progesterone, in sharp contrast with those referring to the use of progestins, are ...two cohort studies carried out in France, where oral micronized progesterone has been used ... Voir le document complet

19

A prospective study of hormone therapy and depression in community-dwelling elderly women: the three city study.

A prospective study of hormone therapy and depression in community-dwelling elderly women: the three city study.

... also the potential for bias in this analysis due to the exclusion of women with missing data. These women were older, with lower education level, more frequently widowed and with overall poorer health. In ... Voir le document complet

24

Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer

Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer

... THRβ1 and THRα2 was assessed according to IRS, determined by evaluating the proportion of positive tumor cells, scored as 0 (no staining), 1 (≤10% of stained cells), 2 (11%–50% of stained cells), 3 (51%–80% ... Voir le document complet

15

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

... B1 and Ki-67 expres- sion [ 17 ] and can be a predictive marker for endocrine therapy resistance [ 20 ...ERK/MAPK and PDGF pathways, which have a significant role in endocrine ... Voir le document complet

10

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

... followed by surgery and radiation, IBC prognosis remains poor with 10-year survival ranging from 37 to 55% ...has a special ...response and dose intensity relationships with alkylating agents ... Voir le document complet

9

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study.

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study.

... characteristics and breast cancer. Design: Longitudinal prospective cohort ...1995 and 2000. Subjects: In total, 69 116 women (age: 45–70 years; mean follow-up: ... Voir le document complet

11

Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models

Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet

12

Hormone therapy and hemostasis among postmenopausal women: a review.

Hormone therapy and hemostasis among postmenopausal women: a review.

... VII and VIII decreased in oral groups without a clear biological explanation for this reduction 28, 29, 31, 34, 37-39, 43, 45, 46 ...early and recent studies may be in part explained by lack ... Voir le document complet

30

Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study.

Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study.

... present study was ...abortion and breast cancer risk, a proportional hazards regression model with age as the time scale was ...relative risk (RR) and the ... Voir le document complet

12

Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?

Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?

... MATERIALS AND METHODS Population The Etude Epidémiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) Study is a prospective cohort study primarily ... Voir le document complet

14

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

... Gauducheau and Centre Catherine de Sienne : Alain Lortholary ;Centre Antoine Lacassagne, Nice: Marc Frénay; Hôpital D'Enfants CHU, Dijon: Laurence Faivre; Institut Bergonié, Bordeaux: Michel Longy; Institut Jean ... Voir le document complet

32

How safe is growth hormone therapy? SAGhE and beyond

How safe is growth hormone therapy? SAGhE and beyond

... Endocrinology and Diabetology, INSERM CIE-5, Hospital and University Paris Diderot, 75019, Paris, France Full list of author information is available at the end of the article Carel International Journal of ... Voir le document complet

2

Regulation of hormone signaling by nuclear receptor interacting proteins.

Regulation of hormone signaling by nuclear receptor interacting proteins.

... (PIDLS and PINLS motifs located respectively between residues 440 to 444 and 565 to 569) which explain partly the repressive action of RIP140 ...I and II HDACs. We show that RIP140 directly binds ... Voir le document complet

18

Development of a multi-gene PCR assay for the prediction of the response to hormone therapy in breast cancer

Development of a multi-gene PCR assay for the prediction of the response to hormone therapy in breast cancer

... longer breast cancer specific survival and distant metastasis free interval in a series of luminal type breast cancers and these associations were independent of other prognostic ... Voir le document complet

145

Show all 10000 documents...